DJ AstraZeneca PLC ADR Falls Tuesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ shed 2.54% to $70.26 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.87% to 17,689.66 and Dow Jones Industrial Average falling 0.95% to 40,829.00.
This was the ADR's second consecutive day of losses.
AstraZeneca PLC ADR closed 19.86% below its 52-week high of $87.68, which the company reached on August 30th.
The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co. $(LLY)$ fell 5.64% to $775.12, Biogen Inc. $(BIIB)$ fell 4.09% to $116.82, and Johnson & Johnson $(JNJ)$ fell 0.34% to $154.47.
Trading volume (4.8 M) remained 1.5 million below its 50-day average volume of 6.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 6, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 06, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.